Significant progress in the production of Dicot's drug candidate
Press release: Uppsala, November 18, 2020. Dicot has produced its second large-scale batch of the drug substance for Libiguin®. The production has improved significantly, which means that 2.5 times as much drug substance has been produced from the same amount of plant raw material compared to previously batch.The production is a semis-synthesis, where plant material is extracted whereafter natural molecules are purified from the extract. These are further synthesized to the drug substance included in the future drug product Libiguin®. Dicot has been working on streamlining and scaling up